SALARIUS PHARMACEUTICALS INC's ticker is SLRX and the CUSIP is 79400X107. A total of 28 filers reported holding SALARIUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,000 | 0.0% | 39,746 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | -50.0% | 39,746 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $16,000 | -20.0% | 39,746 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $20,000 | -51.2% | 39,746 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $41,000 | -2.4% | 39,746 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $42,000 | -28.8% | 39,746 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $59,000 | +63.9% | 39,746 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $36,000 | +5.9% | 39,746 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $34,000 | -34.6% | 39,746 | 0.0% | 0.00% | -40.0% |
| Q2 2020 | $52,000 | +92.6% | 39,746 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $27,000 | -82.0% | 39,746 | 0.0% | 0.00% | -80.0% |
| Q4 2019 | $150,000 | -44.6% | 39,746 | -20.1% | 0.02% | -46.4% |
| Q3 2019 | $271,000 | – | 49,746 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| X-Square Capital, LLC | 97,258 | $39,000 | 0.02% |
| Kepos Capital LP | 548,054 | $218,000 | 0.02% |
| Virtu Financial LLC | 39,476 | $16,000 | 0.00% |
| Laird Norton Wetherby Wealth Management, LLC | 39,746 | $16,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 16,400 | $7,000 | 0.00% |
| NORTHERN TRUST CORP | 65,022 | $26,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 390,115 | $155,000 | 0.00% |
| STATE STREET CORP | 142,552 | $57,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 20,128 | $8,000 | 0.00% |